- Home
- CTMX vs AFB Comparison
CTMX vs AFB Comparison
Compare CTMX & AFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- AFB
- Stock Information
- Founded
- CTMX 2008
- AFB 2001
- Country
- CTMX United States
- AFB United States
- Employees
- CTMX N/A
- AFB N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- AFB Trusts Except Educational Religious and Charitable
- Sector
- CTMX Health Care
- AFB Finance
- Exchange
- CTMX Nasdaq
- AFB Nasdaq
- Market Cap
- CTMX 349.6M
- AFB 293.2M
- IPO Year
- CTMX 2015
- AFB N/A
- Fundamental
- Price
- CTMX $1.93
- AFB $10.90
- Analyst Decision
- CTMX Strong Buy
- AFB
- Analyst Count
- CTMX 4
- AFB 0
- Target Price
- CTMX $5.13
- AFB N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- AFB 74.0K
- Earning Date
- CTMX 11-06-2025
- AFB 01-01-0001
- Dividend Yield
- CTMX N/A
- AFB 3.60%
- EPS Growth
- CTMX 263.20
- AFB N/A
- EPS
- CTMX 0.49
- AFB N/A
- Revenue
- CTMX $141,100,000.00
- AFB N/A
- Revenue This Year
- CTMX N/A
- AFB N/A
- Revenue Next Year
- CTMX N/A
- AFB N/A
- P/E Ratio
- CTMX $3.98
- AFB N/A
- Revenue Growth
- CTMX 18.01
- AFB N/A
- 52 Week Low
- CTMX $0.40
- AFB $8.95
- 52 Week High
- CTMX $3.10
- AFB $11.05
- Technical
- Relative Strength Index (RSI)
- CTMX 41.17
- AFB 80.27
- Support Level
- CTMX $1.90
- AFB $10.84
- Resistance Level
- CTMX $2.16
- AFB $10.70
- Average True Range (ATR)
- CTMX 0.13
- AFB 0.09
- MACD
- CTMX -0.01
- AFB 0.05
- Stochastic Oscillator
- CTMX 7.50
- AFB 89.71
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About AFB AllianceBernstein National Municipal Income Fund Inc
Alliancebernstein National Muni Inc Fd is a diversified, closed-end management investment company. It seeks to provide high current income exempt from regular federal income tax by investing substantially all of its net assets in municipal securities that pay interest that is exempt from federal income tax.